Obstetrics, Gynaecology & Reproductive Health

obstetrics, gynaecology & REPRODUCTIVE HEALTH

nihr portfolio studies - open to recruitment:

OBS UK
Principal Investigator: Dr Archana Panickar
Sponsor: Cardiff University
This study will test the effectiveness of the Obstetric Bleeding Strategy intervention compared to standard care on clinical and psychological outcomes after childbirth and to evaluate the cost effectiveness of the OBS intervention compared to standard care.
Open to Associate PI scheme

OPTIM-I
Principal Investigator: Sarah Petty
Sponsor: The University of Oxford
This study will learn how maternity professionals manage cross cultural communication in consultations.

PROMMIS: Patient reported outcomes for menopause management-interventions study
Principal Investigator: Cheryl Graham
Sponsor: Society for Endocrinology
The aim of this clinical project is to assess whether there is a change in the quality of life of women throughout the menopause transition, as measured by EQ5D and SF-36 questionnaires and collecting directly patient reported data.

VIPS Study: Vaping in pregnancy and its associations with pregnancy and birth outcomes
Principal Investigator: Rachael Taylor
Sponsor: University of Stirling
This study will also help us to understand the most suitable ways to monitor vaping amongst pregnant women, to help us collect longer-term information about vaping behaviour and outcomes.

ADAPT-HEAT
Local Collaborator: Rachael Taylor
Sponsor: University of Newcastle
This study aims to improve the understanding regarding the impact of high ambient temperatures, including heatwaves, on pregnancy and neonatal health in England and use a consensus approach to agree evidence-based guidance and recommendations to reduce the impacts.
Note: We are acting as a Participant Identification Centre for this study only

GILD
Principal Investigator: Dr Sneha Vimalamma
Co-investigator: Dr Kavita Kulavarasalingam
Sponsor: University of Nottingham
Gestational diabetes is a condition where high blood sugar levels develop during pregnancy and resolve after birth. It affects approximately 8% of pregnant women.
Current clinical practice involves ‘tight’ blood sugar monitoring, which means testing blood sugars every hour, with blood sugar levels maintained between 4-7 mmol/L. However, some patients find this approach intrusive and challenging during labour, and that it impacts on their birthing experience. The GILD study aims to find out if a ‘more relaxed’ approach can be taken during labour, where blood sugar levels are tested every 2-4 hours, and kept between 4-10mmol/L.
Individuals who take part will be randomly assigned their treatment group and received either 'tight' blood sugar monitoring or the 'more relaxed' approach. They will be followed up until 6 weeks after birth and also have the opportunity to share their views on the monitoring approaches at optional discussions at about 12 weeks after birth.